Displaying drugs 15326 - 15350 of 15869 in total
Ebvaciclib
Ebvaciclib is under investigation in clinical trial NCT03519178 (A Study of PF-06873600 in People With Cancer).
Investigational
Vorasidenib
Investigational
Temuterkib
Investigational
Bomedemstat
Investigational
Fidarestat
Experimental
6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE
Experimental
Matched Iupac: … 2-ethyl-10-methyl-14-nitro-2,4,10-triazatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3(8),4,6,11,13-hexaen- …
BN-82451
Experimental
Investigational
BI-187004
Investigational
D-naphthyl-1-acetamido boronic acid alanine
Experimental
Soraprazan
Investigational
Docarpamine
Investigational
Cu-64 sartate
Investigational
1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One
Experimental
Henatinib
Henatinib has been used in trials studying the treatment of Advanced Solid Cancer.
Investigational
Matched Iupac: … (3Z)-5-fluoro-3-({5-[(2R)-2-hydroxy-3-(morpholin-4-yl)propyl]-3-methyl-4-oxo-1H,4H,5H,6H,7H,8H-pyrrolo …
1-Amino-2,3-Dihydroxy-5-Hydroxymethyl Cyclohex-5-Ene
Experimental
Matched Iupac: … (1S,2S,3S)-3-amino-5-(hydroxymethyl)cyclohex-4-ene-1,2-diol …
Segesterone
Experimental
ACA 125
An IgG1 murine monoclonal anti-idiotype antibody (Ab2), ACA-125, was developed to bind to anti-CA 125 antibodies. ACA-125 mimics the tumor-associated antigen CA-125, which can be detected in about 80% of ovarian carcinomas.
This new concept of oncological immunotherapy consists of an attempt to trigger the immune system of the host...
Investigational
Matched Description: … To create ACA-125, a hybridoma cell was adapted to serum-free medium and antibody was produced in a hollow …
Displaying drugs 15326 - 15350 of 15869 in total